Literature DB >> 27022444

Infantile onset diabetes mellitus in developing countries - India.

Poovazhagi Varadarajan1.   

Abstract

Infantile onset diabetes mellitus (IODM) is an uncommon metabolic disorder in children. Infants with onset of diabetes mellitus (DM) at age less than one year are likely to have transient or permanent neonatal DM or rarely type 1 diabetes. Diabetes with onset below 6 mo is a heterogeneous disease caused by single gene mutations. Literature on IODM is scanty in India. Nearly 83% of IODM cases present with diabetic keto acidosis at the onset. Missed diagnosis was common in infants with diabetes (67%). Potassium channel mutation with sulphonylurea responsiveness is the common type in the non-syndromic IODM and Wolcott Rallison syndrome is the common type in syndromic diabetes. Developmental delay and seizures were the associated co-morbid states. Genetic diagnosis has made a phenomenal change in the management of IODM. Switching from subcutaneous insulin to oral hypoglycemic drugs is a major clinical breakthrough in the management of certain types of monogenic diabetes. Mortality in neonatal diabetes is 32.5% during follow-up from Indian studies. This article is a review of neonatal diabetes and available literature on IODM from India.

Entities:  

Keywords:  Co-morbid state; Diabetes mellitus; Infants; Monogenic diabetes; Mortality

Year:  2016        PMID: 27022444      PMCID: PMC4807303          DOI: 10.4239/wjd.v7.i6.134

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  59 in total

1.  Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.

Authors:  A S Slingerland; R Nuboer; M Hadders-Algra; A T Hattersley; G J Bruining
Journal:  Diabetologia       Date:  2006-09-19       Impact factor: 10.122

2.  Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2.

Authors:  Amnon Zung; Benjamin Glaser; Revital Nimri; Zvi Zadik
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

3.  Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism.

Authors:  Valérie Senée; Claude Chelala; Sabine Duchatelet; Daorong Feng; Hervé Blanc; Jack-Christophe Cossec; Céline Charon; Marc Nicolino; Pascal Boileau; Douglas R Cavener; Pierre Bougnères; Doris Taha; Cécile Julier
Journal:  Nat Genet       Date:  2006-05-21       Impact factor: 38.330

4.  Clinical and molecular characterization of neonatal diabetes and monogenic syndromic diabetes in Asian Indian children.

Authors:  S Jahnavi; V Poovazhagi; V Mohan; D Bodhini; P Raghupathy; A Amutha; P Suresh Kumar; P Adhikari; M Shriraam; T Kaur; A K Das; J Molnes; P R Njolstad; R Unnikrishnan; V Radha
Journal:  Clin Genet       Date:  2012-08-20       Impact factor: 4.438

5.  Neonatal diabetes with intractable epilepsy: DEND syndrome.

Authors:  Poonam Singh; Sudha Chandrashekhar Rao; Ruchi Parikh
Journal:  Indian J Pediatr       Date:  2014-06-10       Impact factor: 1.967

6.  Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.

Authors:  Andrey P Babenko; Michel Polak; Hélène Cavé; Kanetee Busiah; Paul Czernichow; Raphael Scharfmann; Joseph Bryan; Lydia Aguilar-Bryan; Martine Vaxillaire; Philippe Froguel
Journal:  N Engl J Med       Date:  2006-08-03       Impact factor: 91.245

7.  The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study.

Authors:  Elisa De Franco; Sarah E Flanagan; Jayne A L Houghton; Hana Lango Allen; Deborah J G Mackay; I Karen Temple; Sian Ellard; Andrew T Hattersley
Journal:  Lancet       Date:  2015-07-28       Impact factor: 79.321

8.  Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect.

Authors:  Janani Kumaraguru; Sarah E Flanagan; Siri Atma W Greeley; Roos Nuboer; Julie Støy; Louis H Philipson; Andrew T Hattersley; Oscar Rubio-Cabezas
Journal:  Diabetes Care       Date:  2009-05-12       Impact factor: 19.112

9.  GATA6 mutations cause a broad phenotypic spectrum of diabetes from pancreatic agenesis to adult-onset diabetes without exocrine insufficiency.

Authors:  Elisa De Franco; Charles Shaw-Smith; Sarah E Flanagan; Maggie H Shepherd; Andrew T Hattersley; Sian Ellard
Journal:  Diabetes       Date:  2012-12-06       Impact factor: 9.461

Review 10.  Neonatal diabetes mellitus: a disease linked to multiple mechanisms.

Authors:  Michel Polak; Hélène Cavé
Journal:  Orphanet J Rare Dis       Date:  2007-03-09       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.